Neuberger Berman Group
PAHC icon

Neuberger Berman Group’s Phibro Animal Health PAHC Stock Holding History

Neuberger Berman Group’s Portfolio PAHC Stock Details PAHC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$546K Buy
17,402
+12,838
+281% +$542K ﹤0.01% 1762
2026
Q1 		$252K Buy
+4,564
New +$217K ﹤0.01% 1910
2016
Q3 		– Sell
-286,016
Closed -$5.34M – 1626
2016
Q2 		$5.34M Sell
286,016
-1,428,900
-83% -$29.8M 0.01% 845
2016
Q1 		$46.4M Sell
1,714,916
-26,600
-2% -$763K 0.06% 381
2015
Q4 		$52.5M Buy
1,741,516
+246,855
+17% +$7.92M 0.07% 361
2015
Q3 		$47.3M Buy
1,494,661
+320,740
+27% +$11.7M 0.06% 384
2015
Q2 		$45.7M Buy
1,173,921
+206,524
+21% +$7.12M 0.05% 450
2015
Q1 		$34.3M Buy
967,397
+945,002
+4,220% +$30.4M 0.04% 526
2014
Q4 		$706K Sell
22,395
-18,900
-46% -$523K ﹤0.01% 1288
2014
Q3 		$925K Sell
41,295
-2,150
-5% -$43.1K ﹤0.01% 1263
2014
Q2 		$954K Buy
+43,445
New +$826K ﹤0.01% 1263

Other funds holding PAHC

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Lord, Abbett & Co
Lord, Abbett & Co Jersey City, New Jersey $34.9B AUM 72.7% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return

Neuberger Berman Group's PAHC Position: Q2 2026 in Review

Neuberger Berman Group increased its Phibro Animal Health (PAHC) stake by 281% in Q2 2026, buying an estimated $542K and bringing the position to 17,402 shares worth $546K. The position accounts for ﹤0.01% of the portfolio, ranked #1762.

Neuberger Berman Group first reported a position in PAHC in Q2 2014 and has held it in 11 quarters since. The position peaked at $52.5M in Q4 2015. 208 funds tracked by Wall St. Rank hold PAHC as of Q2 2026.

  • Neuberger Berman Group held 17,402 shares of Phibro Animal Health worth $546K as of Q2 2026.
  • Neuberger Berman Group bought 12,838 Phibro Animal Health shares in Q2 2026, an estimated $542K.
  • Phibro Animal Health made up ﹤0.01% of Neuberger Berman Group's portfolio in Q2 2026, its #1762 holding.
  • Neuberger Berman Group first reported a position in Phibro Animal Health in Q2 2014 and has held it in 11 quarters since.
  • Neuberger Berman Group's Phibro Animal Health position peaked at $52.5M in Q4 2015.
  • 208 funds tracked by Wall St. Rank held Phibro Animal Health as of Q2 2026.

Based on Neuberger Berman Group's 13F filing for Q2 2026, filed 13 Aug 2026.